Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Sirolimus, Gemcitabine and Cisplatin for Patients With High Risk for Cholangiocarcinoma Recurrence

NCT01888302 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01888302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01888302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Sirolimus, Gemcitabine and Cisplatin for Patients With High Risk for Cholangiocarcinoma Recurrence
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2013
Completion date
June 30, 2016
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic complication